Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Fulgent Genetics, |
RCV002503180 | SCV002807133 | likely benign | Focal segmental glomerulosclerosis 4, susceptibility to | 2021-08-30 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001730254 | SCV003277995 | likely benign | not provided | 2024-06-03 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV001730254 | SCV001978227 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001730254 | SCV001980163 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Prevention |
RCV003968523 | SCV004778565 | likely benign | APOL1-related disorder | 2023-02-22 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |